Primary Care

Top Story

Systemic sclerosis more than doubles risk for cancer

October 15, 2019
In the JournalsPerspective

Rivaroxaban does not show noninferiority to vitamin K antagonists in antiphospholipid syndrome

October 14, 2019
Rivaroxaban failed to demonstrate noninferiority to dose-adjusted vitamin K antagonists in patients with thrombotic antiphospholipid syndrome, and the agent even showed…
Meeting News

Metabolic syndrome may play role in HFpEF risk

October 14, 2019
CHICAGO — Patients with metabolic syndrome are at risk for developing HF with preserved ejection fraction, although the mechanisms behind this risk are speculative…
Meeting News

'No holiday from denosumab' preserves bone density gains

October 14, 2019
SAN DIEGO — Taking a ‘holiday’ from many osteoporosis drugs can frequently negate gains in bone density, according to a presentation at the 2019…
More Headlines »